Median time to pain progression was not yet reached in the enzalutamide group ( @ % CI not yet reached to not yet reached ) versus @ ( @ to not yet reached ) months in the placebo group ( HR @ -LSB- @ % CI @ to @ -RSB- ; p = @ ) .